Literature DB >> 8832078

Contribution of calcium-activated potassium channels to the vasodilator effect of bradykinin in the isolated, perfused kidney of the rat.

M Rapacon1, P Mieyal, J C McGiff, D Fulton, J Quilley.   

Abstract

1. NO- and prostaglandin-independent, endothelium-dependent vasodilator responses to bradykinin are attributed to release of a hyperpolarizing factor. Therefore, the contribution of K+ channels to the renal vasodilator effect of bradykinin was examined in rat perfused kidneys that were preconstricted with phenylephrine and treated with NG-nitro-L-arginine (L-NOARG) and indomethacin to inhibit NO and prostaglandin synthesis. 2. The non-specific K+ channel inhibitors, TEA and TBA reduced vasodilator responses to bradykinin and cromakalim but not those to nitroprusside. 3. Glibenclamide, an inhibitor of ATP-sensitive K+ channels, blocked the vasodilator response to cromakalim without affecting responses to bradykinin. 4. Charybdotoxin, a selective inhibitor of Ca(2+)-activated K+ channels, greatly attenuated vasodilator responses to bradykinin without affecting those to cromakalim or nitroprusside. 5. Iberiotoxin and leiurotoxin, inhibitors of large and small conductance Ca(2+)-activated K+ channels, respectively, were without effect on vasodilator responses to bradykinin, cromakalim or nitroprusside. 6. These results implicate K+ channels, specifically Ca(2+)-activated K+ channels of intermediate conductance, in the renal vasodilator effect of bradykinin and, thereby, support a role for a hyperpolarizing factor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8832078      PMCID: PMC1909657          DOI: 10.1111/j.1476-5381.1996.tb15566.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

1.  Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney.

Authors:  D Fulton; J C McGiff; J Quilley
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

Review 2.  Regulatory functions of the vascular endothelium.

Authors:  J R Vane; E E Anggård; R M Botting
Journal:  N Engl J Med       Date:  1990-07-05       Impact factor: 91.245

3.  Calcium entry through receptor-operated channels in bovine pulmonary artery endothelial cells.

Authors:  A Johns; T W Lategan; N J Lodge; U S Ryan; C Van Breemen; D J Adams
Journal:  Tissue Cell       Date:  1987       Impact factor: 2.466

4.  Neither nitric oxide nor nitroglycerin accounts for all the characteristics of endothelially mediated vasodilatation of pig coronary arteries.

Authors:  J L Bény; P C Brunet
Journal:  Blood Vessels       Date:  1988

5.  Purification and characterization of a unique, potent inhibitor of apamin binding from Leiurus quinquestriatus hebraeus venom.

Authors:  G G Chicchi; G Gimenez-Gallego; E Ber; M L Garcia; R Winquist; M A Cascieri
Journal:  J Biol Chem       Date:  1988-07-25       Impact factor: 5.157

Review 6.  Pharmacological and physiological significance of ion channels and factors that modulate them in vascular tissues.

Authors:  H Kuriyama; K Kitamura; H Nabata
Journal:  Pharmacol Rev       Date:  1995-09       Impact factor: 25.468

7.  Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus.

Authors:  A Galvez; G Gimenez-Gallego; J P Reuben; L Roy-Contancin; P Feigenbaum; G J Kaczorowski; M L Garcia
Journal:  J Biol Chem       Date:  1990-07-05       Impact factor: 5.157

8.  Increased vascular responsiveness to bradykinin in kidneys of spontaneously hypertensive rats. Effect of N omega-nitro-L-arginine.

Authors:  V Cachofeiro; A Nasjletti
Journal:  Hypertension       Date:  1991-11       Impact factor: 10.190

9.  Effects of bradykinin in the rat isolated perfused heart: role of kinin receptors and endothelium-derived relaxing factor.

Authors:  A R Baydoun; B Woodward
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

10.  Two mechanisms mediate relaxation by bradykinin of pig coronary artery: NO-dependent and -independent responses.

Authors:  C L Cowan; R A Cohen
Journal:  Am J Physiol       Date:  1991-09
View more
  7 in total

Review 1.  Connexins and gap junctions in the EDHF phenomenon and conducted vasomotor responses.

Authors:  Cor de Wit; Tudor M Griffith
Journal:  Pflugers Arch       Date:  2010-04-09       Impact factor: 3.657

2.  KCa 3.1 channels maintain endothelium-dependent vasodilatation in isolated perfused kidneys of spontaneously hypertensive rats after chronic inhibition of NOS.

Authors:  Serge Simonet; Marc Isabelle; Mélanie Bousquenaud; Nicolas Clavreul; Michel Félétou; Christine Vayssettes-Courchay; Tony J Verbeuren
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

3.  Role of K+ channels in EDHF-dependent relaxation induced by acetylcholine in canine coronary artery.

Authors:  Y Nakashima; Y Toki; Y Fukami; M Hibino; K Okumura; T Ito
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

4.  A human intermediate conductance calcium-activated potassium channel.

Authors:  T M Ishii; C Silvia; B Hirschberg; C T Bond; J P Adelman; J Maylie
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

5.  Signal transduction pathways involved in kinin B(2) receptor-mediated vasodilation in the rat isolated perfused kidney.

Authors:  K Bagaté; M Grima; J L Imbs; W D Jong; J J Helwig; M Barthelmebs
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

6.  Studies of the role of endothelium-dependent nitric oxide release in the sustained vasodilator effects of corticotrophin releasing factor and sauvagine.

Authors:  D M Barker; R Corder
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

Review 7.  Endothelium-dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis?

Authors:  Tudor M Griffith
Journal:  Br J Pharmacol       Date:  2004-03       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.